Dr. Agarwal’s Well being Care Inventory Value: Lately listed Dr. Agarwals Healthcare shares rose by about 8 % within the day on March 20 and the worth on BSE went as much as Rs 448.30. On the closure of the enterprise, the inventory gained 4 % to settle at Rs 434.35. Motilal Oswal, one other brokerage agency for the corporate’s shares, has began protection with ‘bye’ score. The goal worth is saved at Rs 510 per share. That is 17 % larger than the closing worth of the inventory on BSE on 20 March. Agrawals Healthcare shares had been listed on BSE and NSE on 4 February 2025. The corporate’s IPO of Rs 3,027.26 crore was about 1.5 occasions. The corporate’s market cap is Rs 13,700 crore. Dr. Agrawals gives healthcare iCare providers. It’s the mum or dad firm of Dr Agarwals Eye Hospital. It has a 71.90 % stake in Dr. Agrawals Eye Hospital. A document of Rs 370.10 has gone as much as excessive. Agarwal’s Well being Care Dr. Agrawals Healthcare’s inventory has strengthened 4 % in a month. It has seen a document excessive of Rs 463.85 on BSE to this point and document of Rs 370.10. The corporate had 32.45 % stake within the firm as of three February 2025. The higher circuit for the inventory is at Rs 499.70 and the decrease circuit at Rs 333.20. The circuit restrict is 20 %. Motilal Oswal wrote in his word that Dr. Agarwal’s Healthcare had 221 amenities until the top of December 2024. The corporate generates income from diversion service portfolio, together with surgical procedure (65%), consultations (14%), and product gross sales (optical 13percentand prescription drugs 8%). Brokerage is anticipated to develop from the corporate’s income from 21% CAGR and Ebitda 23% CAGR, as a result of which the income will attain Rs 2,490 crore and Ebitda will attain Rs 690 crore by FY 2027. Disclaimer: The recommendation or thought specialists/brokerage companies have their very own private views. The web site or administration will not be answerable for this. Moneycontrol advises to customers that all the time search the recommendation of licensed specialists earlier than taking any funding choice.
